50,000 New Drug Tests Among Brexit Worries for Pharma Companies

Bookmark
(Bloomberg) -- Global drugmakers from Johnson & Johnson to AstraZeneca Plc warned that potential trade and regulatory hurdles may burden them with a host of additional costs after Britain leaves th...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.